Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

Changes in Peripheral Blood Population Numbers and Type. Clinical Trial

Official title: Pilot Study for the Detection of Stem/Progenitor Cell Up-regulation Using Aldagen BRIGHT Technology in Peripheral Blood After Hyperbaric Oxygen Therapy (HBOT) Treatment

Status Enrolling by invitation

Clinical Trial Summary

This is an observational research study whose purposes are to see the effects of repeated hyperbaric oxygen therapy treatments on the levels of stem/progenitor cells in peripheral circulating blood following five days of treatment, 90 minutes per day at 2.0 atmospheres absolute in 100% USP Grade Oxygen. Hyperbaric oxygen has a greater oxygen concentration than air at sea level. In this research, the concentration of oxygen will be twice the level of oxygen at sea level.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Changes in Peripheral Blood Population Numbers and Type.

• NCT number: NCT01740908
• Study type: Observational
• Source: Restorix Research Institute, LLLP
• Status: Enrolling by invitation
• Phase: N/A
• Start date: December 2012
• Completion date: January 2013